Runben Biotechnology Co., Ltd. (SHA:603193)

Runben Biotechnology Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,531	9,447	7,356	-	-	-
Market Cap Growth	114.91%	28.44%	-	-	-	-
Enterprise Value	10,147	9,054	6,808	-	-	-
Last Close Price	28.50	23.21	17.79	-	-	-
PE Ratio	37.60	31.47	32.54	-	-	-
Forward PE	28.85	26.27	26.80	-	-	-
PS Ratio	8.29	7.17	7.12	-	-	-
PB Ratio	5.43	4.54	3.83	-	-	-
P/TBV Ratio	5.57	4.66	3.87	-	-	-
P/FCF Ratio	61.65	51.62	30.79	-	-	-
P/OCF Ratio	42.62	36.73	29.13	-	-	-
EV/Sales Ratio	7.29	6.87	6.59	-	-	-
EV/EBITDA Ratio	29.32	27.62	25.94	-	-	-
EV/EBIT Ratio	31.20	29.38	28.06	-	-	-
EV/FCF Ratio	54.25	49.47	28.50	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.02	-
Debt / EBITDA Ratio	0.01	0.01	0.02	0.04	0.07	-
Debt / FCF Ratio	0.01	0.02	0.02	0.06	-	-
Asset Turnover	0.64	0.62	0.73	1.16	1.26	2.01
Inventory Turnover	3.58	5.23	4.64	4.93	5.40	5.64
Quick Ratio	8.26	10.58	16.93	3.97	3.64	3.72
Current Ratio	9.71	11.63	18.04	5.28	4.56	5.85
Return on Equity (ROE)	15.14%	15.00%	17.10%	24.93%	29.72%	48.88%
Return on Assets (ROA)	9.31%	9.09%	10.66%	15.06%	17.69%	30.29%
Return on Capital (ROIC)	9.95%	9.61%	11.42%	17.02%	19.86%	34.46%
Return on Capital Employed (ROCE)	15.30%	14.80%	12.60%	24.30%	22.90%	42.40%
Earnings Yield	2.68%	3.18%	3.07%	-	-	-
FCF Yield	1.62%	1.94%	3.25%	-	-	-
Dividend Yield	1.58%	1.77%	0.96%	-	-	-
Payout Ratio	44.04%	45.32%	-	2.15%	25.65%	-
Buyback Yield / Dilution	-12.06%	-14.85%	-3.71%	-1.61%	-9.69%	-499.54%
Total Shareholder Return	-10.47%	-13.09%	-2.76%	-1.61%	-9.69%	-499.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.